About PPA   |   Sign In   |   Join Now
LVPA: Re-Evaluating the Overall Risk/Benefit in Selecting an Oral P2Y12 Inhibitor - CANCELLED
Tell a Friend About This EventTell a Friend
LVPA: Re-Evaluating the Overall Risk/Benefit in Selecting an Oral P2Y12 Inhibitor - CANCELLED

3/26/2020
When: Thursday, March 26
6:00 PM
Where: Melt
2880 Center Valley Parkway
Center Valley, Pennsylvania  18034
United States
Presenter: Renato Derita
Contact: Bill Ceh
484-201-6252

« Go to Upcoming Event List  

LVPA: Re-Evaluating the Overall Risk/Benefit in Selecting an Oral P2Y12 Inhibitor 

Hosted by AstraZeneca

 

Click here for a flyer with more information!

 

Location: Melt

                 2880 Center Valley Parkway

                 Center Valley, PA 18034

 

Schedule:

6:00 PM - 9:00 PM: Presentation

 

Presenter:

Renato Derita

 

 

This event is open to Pharmacists and Technicians! The room holds 20 people! PPA is not taking reservations for this event! Please RSVP to Bill Ceh at 484-201-6252 by March 23, 2020!

 

Association Management Software Powered by YourMembership  ::  Legal